Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In a study of 50 healthy adults, Keshohills hair oil was shown to be effective in reducing hair loss and treating seborrheic dermatitis.

This review discusses the scalp microinfusion MMP® technique for hair loss treatment and reports no new results; it emphasizes the need for more standardized studies.

This source outlines the potential effects of treatments commonly used in trichology on SARS-CoV-2 infection and offers a guide for managing trichological patients during the COVID-19 era, addressing the challenges of safely visiting and treating patients.

This study revealed that Madayantika siddha taila, containing sesame oil, showed effectiveness in treating Darunaka (seborrhea capitis) by addressing aggravated Vata and Kapha doshas.

This study found that Scalp med®, a solution including minoxidil, significantly improved hair count and thickness in men with androgenetic alopecia after 24 weeks of treatment.

In this case study, a woman with non-classical adrenal hyperplasia experienced reduced levels of specific adrenal steroids and less scalp hair loss after self-treating with Ashwagandha for six months.

This study found that a combined treatment using autologous scalp‐derived micrografts and allogeneic dental pulp stem cell‐derived conditioned medium was well-tolerated and improved hair characteristics in 69.5% of patients with male androgenetic alopecia, particularly increasing hair diameter and hair number per follicular unit.

In this analysis of the BRAVE-AA trials, a significant number of patients with severe alopecia areata treated with baricitinib reached complete or nearly complete scalp coverage (SALT score ≤10 or ≤5) over 52 weeks, particularly among those with less severe baseline characteristics.

In this self-controlled comparative study of 16 women with Female Pattern Hair Loss, MMP® with Minoxidil showed a better response in the parietal-vertex regions in less advanced cases compared to standard Minoxidil treatment, though overall effectiveness was similar.

This integrative literature review found that oral Minoxidil is a favorable alternative for individuals intolerant to topical application, effectively treating various forms of alopecia, though side effects like increased hair growth and minor dermatological reactions are noted.

This study found that a new topical agent, Scalp medⓇ, significantly improved hair count and thickness in men with androgenetic alopecia after 24 weeks of treatment.

In this study, a combination of GFM-lotion with autologous PRP treatment improved efficacy in treating androgenic alopecia compared to PRP alone, as shown by significant improvements in clinical assessments over 3 months.

In this study, topically applying 2% ketoconazole cream twice daily for 21 days was found effective in treating dermatophytosis caused by Microsporum canis in cats, showing approximately 85% improvement in skin lesions and the disappearance of the fungi.

Dovobet ointment used overnight effectively reduces scalp psoriasis severity and itch.

This review summarizes treatments for scalp involvement in dermatomyositis and suggests that therapies like low-dose naltrexone and platelet-rich plasma may warrant further investigation, although evidence remains limited.

This study links scalp pruritus in lichen planopilaris and its variants to the inflammation-induced release of substance P and calcitonin gene-related peptide by sensory nerves around hair follicle inflammation sites.

This review highlights the potential of nanoparticle-based shampoos to improve dandruff treatment and cosmetic performance while noting concerns about nanoparticle toxicity and environmental safety that require further investigation.

This study reported that platelet-rich fibrin (iPRF) therapy may improve scalp health and hair appearance in women, showing beneficial changes in scalp hydration, redness, oiliness, and hair density, thickness, and loss.

In this study, micropigmentation of scalp and eyebrow scars showed satisfying cosmetic outcomes in 94% of patients with no complications, as pigments remained stable in the superficial dermis after three weeks.

This study found that 4-MA is a potent inhibitor of testosterone 5α-reductase in human tissues, promising potential for treating androgen-dependent skin conditions like male pattern baldness.

This review examines the debated link between iron deficiency and nonscarring scalp alopecia in women, offering no new clinical results but emphasizing the need for further research and well-designed trials.

This study found that dupilumab treatment in alopecia areata significantly suppressed Th2-related markers and increased hair keratin levels, suggesting a potential role of Th2 cytokines in the disease's pathogenesis.

This article reports on a case where treatment-resistant giant unilateral Bowen’s disease of the scalp responded to radiotherapy, but provides no further clinical details or results.

In this report, a rare case of scalp arteriovenous fistula following hair transplantation was successfully treated using direct puncture embolization with n-butyl cyanoacrylate glue, demonstrating effective management of this condition.

This study suggests that integrating scalp reduction into male pattern baldness treatment may reduce time, trouble, and cost by about one third compared to conventional hair restoration methods.

Using powdered umbilical remnant allograft can effectively treat chronic scalp wounds resistant to traditional treatments.

This study found that SESA oil significantly improved hair and scalp ailments more than coconut oil, with no adverse reactions reported during the study period.

In this study, baricitinib treatment led to significant regrowth of scalp, eyebrow, and eyelash hair in alopecia areata patients compared to placebo, with higher effectiveness seen at the 4-mg dose.

In this case report, researchers described a treatment for post-aplasia cutis congenita alopecia using follicular unit transplantation, platelet-rich plasma, and fat grafting, which significantly improved hair follicles, skin quality, and sensitivity in the affected scalp area.

This case report documents an instance of erosive pustular dermatosis of the scalp in an 84-year-old man, highlighting that this rare condition, often linked with androgenic alopecia and autoimmune diseases, typically responds to high-potency topical steroid treatment.